Vlado Perkovic

20PUBLICATIONS
85CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsPharmacogenomicsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 19, 2026
Sex disparities in receiving evidence-based medications in patients with CKD.

|Mar 29, 2025
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials.

Matthew M Y Lee, Naveed Sattar, Rodica Pop-Busui

|Aug 30, 2024
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Brendon L Neuen, Robert A Fletcher, Lauren Heath

|Apr 07, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.

Siddharth M Patel, Yu Mi Kang, KyungAh Im

|Jan 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial.

Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury

|Nov 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.

Brendon L Neuen, Hiddo J L Heerspink, Priya Vart

Pageof 4

Frequent Collaborators

10 joint publications

Hiddo L Heerspink

9 joint publications

Brendon L Neuen

9 joint publications

Bruce Neal

7 joint publications

Clare Arnott